Letters sent to healthcare professionals in May 2016

In May 2016, letters were sent regarding Nexplanon (etonogestrel implant) and ERWINASE.

In May 2016, letters were sent regarding:

Article citation: Drug Safety Update vol 9 issue 11, June 2016: 4.

Published 15 June 2016